Founder of 7 different companies, notably: Atlas Antibodies AB, Amylonix AB and Scandiedge Therapeutics AB, Karin Marianne Hansson is an entrepreneur and businessperson who has been at the helm of 7 different companies and currently holds the position of Chief Executive Officer of Scandibio Therapeutics AB (which she founded), Chief Executive Officer & Director at Amylonix AB (which she founded), Chief Executive Officer & Director at Scandiedge Therapeutics AB (which she founded), Chief Executive Officer & Director at Mariham Consulting AB, Chief Executive Officer & Director at Protemedge AB (which she founded) and Chief Executive Officer for A05 Diagnostics AB (which she founded). Karin Marianne Hansson is also on the board of Q-linea AB and Intervacc AB.

In her past career she was Chief Executive Officer for Atlas Antibodies AB (she founded the company in 2006), Manager-Business Development at Affibody Medical AB and Principal at Affibody AB (a subsidiary of Affibody Medical AB) and Deputy Director at Antibodies Incentive AB.

She received a doctorate and a graduate degree from Royal Institute of Technology.